Riskpilot← Back to searchSign inGet full accessDr Valis AB
ABActiveOrg 5590507488Lördagsvägen 50General medical practice activities · NACE 8621Est. 20161 employees
Revenue 2025
SEK 10K
EBITDA margin
6.8%
+108% vs 2024
Equity ratio
99.3%
Financial strength
Net profit 2025
SEK 30
+100% vs 2024
| Revenue | SEK 10K | — |
| EBITDA | SEK 650 | +108% |
| Net profit | SEK 30 | +100% |
| Total assets | SEK 76K | +1% |
| Equity | SEK 75K | +0% |
| Employees | 1 | — |
Legal name
Dr Valis AB
Org number
5590507488
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
10 februari 2016
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-05-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva medicinsk konsultverksamhet inom öppen- och slutenvård, medicinsk utbildning och information, förvalta värdepapper, äga och förvalta fast och lös egendom samt bedriva därmed förenlig verksamhet.
Address
Lördagsvägen 50
Email
valis.erik@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 44 | 218 | 6 | 0 | 10 |
| Staff expenses | — | −0 | −0 | −0 | −0 |
| EBITDA | 24 | 198 | −14 | −8 | 1 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | 24 | 198 | −14 | −8 | 1 |
| Net financials | −1 | −1 | −2 | −0 | −1 |
| Profit before tax | 23 | 197 | −16 | −8 | 0 |
| Tax | −5 | −41 | — | — | — |
| Net profit | 18 | 156 | −16 | −8 | 0 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 79 | 315 | 84 | 75 | 76 |
| Equity | 68 | 225 | 84 | 75 | 75 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 11 | 91 | 1 | 0 | 1 |
| Total debt | 11 | 91 | 1 | — | 1 |
EBITDA margin
6.8%
This company
15.8%
Market median
-57% vs market
20212025
Equity ratio
99.3%
This company
38.2%
Market median
+160% vs market
20212025
Return on equity
0.0%
This company
18.4%
Market median
-100% vs market
20212025
Net profit margin
0.3%
This company
8.1%
Market median
-96% vs market
20212025
Asset turnover
0.13×
This company
1.12×
Market median
-88% vs market
20212025
Debt / equity
0.01×
This company
0.62×
Market median
+98% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-06-01 – 2025-05-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-06-01 – 2024-05-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-06-01 – 2023-05-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-06-01 – 2022-05-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-06-01 – 2021-05-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
EP Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Dr Valis AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Erik Per Josef Valis | Chief Executive Officer | 0 companies |
| Henrik Jan Martin Valis | Deputy Board Member | 0 companies |